The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
The battle of “nano” paclitaxel
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gradishar, W. J., Tjulandin, S., Davidson, N., Shaw, H., Desai, N., Bhar, P., Hawkins, M., & O'Shaughnessy, J. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.937 · Cited by 2,153
Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1634 · Cited by 1,175
Challenges in Development of Nanoparticle-Based Therapeutics
Desai, N. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9339-4 · Cited by 1,173
Kim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Ibrahim, N. K., Desai, N. P., Legha, S. S., Soon‐Shiong, P., Theriault, R. L., Rivera, E., Esmaeli, B., Ring, S. E., Bedikian, A. Y., Hortobágyi, G. N., et al. (2002) · PubMed · Cited by 627
Hamaguchi, T., Matsumura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I., Nakatomi, I., Yokoyama, M., Kataoka, K., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602479 · Cited by 565
Desai, N., Trieu, V., Damascelli, B., & Soon-Shiong, P. (2009) · Translational Oncology · doi:10.1593/tlo.09109 · Cited by 396
Zhang, J. A., Anyarambhatla, G., Ma, L., Ugwu, S., Xuan, T., Sardone, T., & Ahmad, I. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.06.009 · Cited by 334
Hamaguchi, T., Kato, K., Yasui, H., Morizane, C., Ikeda, M., Ueno, H., Muro, K., Yamada, Y., Okusaka, T., Shirao, K., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603855 · Cited by 290
Design considerations for nanotherapeutics in oncology
Stylianopoulos, T., & Jain, R. K. (2015) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.07.015 · Cited by 280
Kato, K., Chin, K., Yoshikawa, T., Yamaguchi, K., Tsuji, Y., Esaki, T., Sakai, K., Kimura, M., Hamaguchi, T., Shimada, Y., et al. (2012) · Investigational New Drugs · doi:10.1007/s10637-011-9709-2 · Cited by 237
Randomized Crossover Pharmacokinetic Study of Solvent-Based Paclitaxel and nab -Paclitaxel
Gardner, E. R., Dahut, W. L., Scripture, C. D., Jones, J., Aragon-Ching, J. B., Desai, N., Hawkins, M. J., Sparreboom, A., & Figg, W. D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4592 · Cited by 226
Shi, Y., van der Meel, R., Theek, B., Oude Blenke, E., Pieters, E. H. E., Fens, M. H. A. M., Ehling, J., Schiffelers, R. M., Storm, G., van Nostrum, C. F., et al. (2015) · ACS Nano · doi:10.1021/acsnano.5b00929 · Cited by 214
Self-citationDevelopment of liposomal formulations: From concept to clinical investigations
Fan, Y., & Zhang, Q. (2013) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2013.07.010 · Cited by 206
High affinity binding of paclitaxel to human serum albumin
Paál, K., Müller, J., & Hegedûs, L. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02107.x · Cited by 191
Ahn, H. K., Jung, M., Sym, S. J., Shin, D. B., Kang, S. M., Kyung, S. Y., Park, J.-W., Jeong, S. H., & Cho, E. K. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2498-5 · Cited by 183
Suspected anaphylactic reaction to Cremophor EL.
Dye, D., & Watkins, J. (1980) · BMJ · doi:10.1136/bmj.280.6228.1353 · Cited by 169
Awada, A. H., Bondarenko, I., Bonneterre, J. M., Nowara, E., Ferrero, J.-M., Bakshi, A. V., Wilke, C., & Piccart, M. J. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu025 · Cited by 142
Park, I. H., Sohn, J. H., Kim, S. B., Lee, K. S., Chung, J. S., Lee, S. H., Kim, T. Y., Jung, K. H., Cho, E. K., Kim, Y. S., et al. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2016.289 · Cited by 133
Fasol, U., Frost, A., Büchert, M., Arends, J., Fiedler, U., Scharr, D., Scheuenpflug, J., & Mross, K. B. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr300 · Cited by 101
A clinical study on the premedication of paclitaxel liposome in the treatment of solid tumors
Zhang, Q., Huang, X., & Gao, L. (2008) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2008.10.001 · Cited by 93
Slingerland, M., Guchelaar, H., Rosing, H., Scheulen, M. E., van Warmerdam, L. J. C., Beijnen, J. H., & Gelderblom, H. A. J. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.10.009 · Cited by 89
Hasenstein, J. R., Shin, H., Kasmerchak, K., Buehler, D. G., Kwon, G. S., & Kozak, K. R. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0987 · Cited by 85
Eichhorn, M., Ischenko, I., Luedemann, S., Strieth, S., Papyan, A., Werner, A., Bohnenkamp, H. R., Guenzi, E., Preißler, G., Michaelis, U., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24846 · Cited by 85
Casali, P. G. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm517 · Cited by 80
Albumin-Bound Paclitaxel plus Gemcitabine in Pancreatic Cancer
Hoff, D. D. V., Goldstein, D., & Renschler, M. F. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1314761 · Cited by 76
Antitumor effect and toxicity of Lipusu in rat ovarian cancer xenografts
Ye, L., He, J., Hu, Z., Dong, Q., Wang, H., Fu, F., & Tian, J. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.11.004 · Cited by 76
Tamura, T., Sasaki, Y., Nishiwaki, Y., & Saijo, N. (1995) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1995.tb03316.x · Cited by 67
Efficacy and tissue distribution of DHP107, an oral paclitaxel formulation
Hong, J. W., Lee, I., Kwak, Y. H., Park, Y., Sung, H. C., Kwon, I. C., & Chung, H. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0261 · Cited by 60
Jain, M. M., Gupte, S. U., Patil, S. G., Pathak, A. B., Deshmukh, C. D., Bhatt, N., Haritha, C., Babu, G., Bondarde, S. A., Digumarti, R., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3736-9 · Cited by 57
Dranitsaris, G., King, J., Kaura, S., Yu, B., & Zhang, A. (2015) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s82194 · Cited by 45
Lazzaro, C. R., Bordonaro, R., Cognetti, F., Fabi, A., Placido, S. D., Marchetti, Botticelli, A., Pronzato, P., Martelli, & Arpino, G. (2013) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s41850 · Cited by 30
Hong, Y. S., Kim, K., Lim, H., Bae, K., Ryu, M., Lee, J., Chang, H. M., Kang, Y., Kim, H., & Kim, T. W. (2012) · Investigational New Drugs · doi:10.1007/s10637-012-9841-7 · Cited by 27
McLeod, E., Lloyd, A. M., Samyshkin, Y., et al. (2010) · Value in Health · doi:10.1016/s1098-3015(11)71991-x · Cited by 5
Jain, M. M., Patil, S., Pathak, A. B., Deshmukh, C. D., Bhatt, N., Babu, K. G., Haritha, C., Bondarde, S. A., Digumarti, R., Bajpai, J., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.1069 · Cited by 4
Ma, W. W., Lam, E. T., Dy, G. K., Diamond, J. R., Zhao, Y., Bui, L. A., Fetterly, G. J., Abramowitz, W., Harning, R., Pencheva, P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.2557 · Cited by 4
Cited by
A Compressive Review about Taxol®: History and Future Challenges
Gallego-Jara, J., Lozano-Terol, G., Sola-Martínez, R. A., Cánovas-Díaz, M., & de Diego Puente, T. (2020) · Molecules · doi:10.3390/molecules25245986 · Cited by 344
What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right
Sun, D., Zhou, S., & Gao, W. (2020) · ACS Nano · doi:10.1021/acsnano.9b09713 · Cited by 263
Lübtow, M. M., Haider, M. S., Kirsch, M., Klisch, S., & Luxenhofer, R. (2019) · Biomacromolecules · doi:10.1021/acs.biomac.9b00618 · Cited by 111
Zhang, C., Zhang, X., Zhao, W., Zeng, C., Li, W., Li, B., Luo, X., Li, J., Jiang, J., Deng, B., et al. (2019) · Nano Research · doi:10.1007/s12274-019-2308-9 · Cited by 61
Grüne, M., Luxenhofer, R., Iuga, D., Brown, S. P., & Pöppler, A.-C. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00614a · Cited by 37
Metadata
- Authors
- Sofias, A. M., Dunne, M., Storm, G., & Allen, C.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 122
- Pages
- 20-30
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2594239688
- Cited by
- 401
- References
- 36
- FWCI
- 2.04
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.